BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3189764)

  • 1. Circular dichroism for the determination of amphotericin B binding to liposomes.
    Jullien S; Vertut-Croquin A; Brajtburg J; Bolard J
    Anal Biochem; 1988 Jul; 172(1):197-202. PubMed ID: 3189764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.
    Jullien S; Brajtburg J; Bolard J
    Biochim Biophys Acta; 1990 Jan; 1021(1):39-45. PubMed ID: 2403812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the existence of an amphotericin B--sterol complex in lipid vesicles and in propanol-water systems.
    Gruda I; Bolard J
    Biochem Cell Biol; 1987 Mar; 65(3):234-8. PubMed ID: 3580172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium.
    Bolard J; Legrand P; Heitz F; Cybulska B
    Biochemistry; 1991 Jun; 30(23):5707-15. PubMed ID: 2043613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids.
    Jullien S; Contrepois A; Sligh JE; Domart Y; Yeni P; Brajtburg J; Medoff G; Bolard J
    Antimicrob Agents Chemother; 1989 Mar; 33(3):345-9. PubMed ID: 2658784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study.
    Vertut-Croquin A; Bolard J; Chabbert M; Gary-Bobo C
    Biochemistry; 1983 Jun; 22(12):2939-44. PubMed ID: 6871175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles.
    Milhaud J; Hartmann MA; Bolard J
    Biochimie; 1989 Jan; 71(1):49-56. PubMed ID: 2497797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Dec; 193(1):97-106. PubMed ID: 10581426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.
    Legrand P; Chéron M; Leroy L; Bolard J
    J Drug Target; 1997; 4(5):311-9. PubMed ID: 9169988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasma proteins and lipoproteins with amphotericin B.
    Brajtburg J; Elberg S; Bolard J; Kobayashi GS; Levy RA; Ostlund RE; Schlessinger D; Medoff G
    J Infect Dis; 1984 Jun; 149(6):986-97. PubMed ID: 6376657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of amphotericin B ion channels in lipid bilayers.
    Fujii G; Chang JE; Coley T; Steere B
    Biochemistry; 1997 Apr; 36(16):4959-68. PubMed ID: 9125518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
    Juliano RL; Grant CW; Barber KR; Kalp MA
    Mol Pharmacol; 1987 Jan; 31(1):1-11. PubMed ID: 3807887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes.
    Kagan S; Ickowicz DE; Domb AJ; Dagan A; Polacheck I
    Med Mycol; 2017 Jun; 55(4):414-421. PubMed ID: 28339539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and nonaromatic heptaene antibiotics (vacidin A and amphotericin B).
    Bolard J; Cheron M; Mazerski J
    Biochem Pharmacol; 1984 Nov; 33(22):3675-80. PubMed ID: 6508823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
    Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
    Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of nystatin and amphotericin B with sterol-free L-dilauroylphosphatidylcholine bilayers resulting in the formation of dichroic lipid superstructures.
    Milhaud J; Michels B
    Chem Phys Lipids; 1999 Sep; 101(2):223-35. PubMed ID: 10533264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular dichroism study of interactions of Fungizone or AmBisome forms of amphotericin B with human low density lipoproteins.
    Barwicz J; Beauregard M; Tancrède P
    Biopolymers; 2002; 67(1):49-55. PubMed ID: 11842413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of hepatocytes from attack by the pore former amphotericin B.
    Binet A; Bolard J
    Biochem J; 1988 Jul; 253(2):435-40. PubMed ID: 3178722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
    Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.